Patent classifications
C07F15/025
Method for producing beta-hematin crystal comprising step of heating
This invention provides a method of preparing a β-hematin crystal comprising a step of heating, the β-hematin crystal obtained by such method, and a vaccine adjuvant composition containing the β-hematin crystal. The β-hematin crystal has a needle-like morphology, it has an average particle size of 0.6 to 1.2 μm, and it exhibits main peaks characteristics for angles of diffraction (2θ) of 7.4°, 12.2°, 21.6°, and 24.1° in an X-ray diffraction pattern obtained by powder X-ray diffractometry with Cu—Kα rays (with each peak including a plus-minus 0.2° diffraction angle).
METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF
A method of preparing a Metal Organic Framework (MOF) with an acoustically-driven microfluidic platform, the method comprising: depositing a liquid comprising MOF precursors on a piezoelectric substrate of an acoustic microfluidic platform, the MOF precursors comprising a metal ion and an organic ligand, applying acoustic irradiation to the liquid to induce azimuthal liquid recirculation, which causes formation of the MOF within the liquid, and isolating the MOF.
METHOD FOR PREPARING BIOGENIC GUANIDINE COMPLEX, METHOD FOR PREPARING POLYETHYLENE TEREPHTHALATE (PET), AND METHOD FOR PREPARING POLY (ETHYLENE ISOPHTHALATE-CO-TEREPHTHALATE) (PEIT)
A method for preparing a biogenic guanidine complex, the method including: mixing dimethyl sulfoxide (DMSO) with water in a volume ratio thereof of 1:1 to yield a solvent DMSO-H.sub.2O; adding organic guanidine (G) and a compound MX.sub.2 in a molar ratio G/MX.sub.2=1:1 or 2:1 to the solvent DMSO-H.sub.2O, where the organic guanidine (G) is selected from arginine (Arg), guanidinoacetic acid (Gaa), creatine (Cra), creatinine (Cran), guanine (Gua), and agmatine (Agm); M represents Fe.sup.2+, Mg.sup.2+, or Zn.sup.2+; and X represents Cl.sup.−, CH.sub.3COO.sup.−, or CH.sub.3CH(OH)COO.sup.−; stirring the solvent DMSO-H.sub.2O containing the organic guanidine and the compound MX.sub.2; recycling the solvent DMSO-H.sub.2O through vacuum distillation and obtaining a solid; transferring the solid to a Buchner funnel, and washing the solid with deionized water and ethanol consecutively; and removing the deionized water and ethanol through vacuum filtration, and drying the solid.
METHOD FOR PRODUCING AN ADSORBENT FROM ORGANOMETALLIC FRAMEWORK STRUCTURES (MOF)
The present invention relates to a method for the production of an absorbent made of metal-organic framework structures (MOF), in the case of which at least one metal salt is converted with at least one organic ligand. The conversion is effected at a temperature greater than 100° C. in a solvent mixture which comprises DMSO and water. The invention relates in addition to an adsorbent produced with the method according to the invention or to a substrate coated with such an adsorbent and also to possibilities of use of such an adsorbent or substrate.
PHYTIC ACID BASED METALLOGEL AND APPLICATIONS THEREOF
The present invention to provide a highly proton conducting metal organic material constituting of phosphate ester based ligand immobilized via gelation with Fe.sup.3+ ion in DMF which is used as conducting electrolyte in PEFMCs.
Iron metal organic framework materials
The invention relates to an improved process for preparing metal-organic framework materials, metal-organic frameworks obtainable by such processes, methods using the same, and the use thereof. The process of the invention provides an improved process for preparing metal-organic frameworks in particular monocrystalline metal-organic frameworks having large crystal sizes. The invention also relates to metal organic frameworks comprising iron or titanium, and their uses.
Transition Metal Macrocyclics as MRI Contrast Agents for Molecular Imaging
In one aspect, the present disclosure relates to a Magnetic Resonance Imaging (MRI) and Spectroscopic Imaging (MRSI) agent wherein the agent comprises a polyazamacrocyclic ligand coordinated to a first row transition metal ion. In another aspect, the disclosure relates to a method of using the MRI/MRSI agents of the present disclosure to monitor tissue temperature and/or pH in a patient in need thereof. In another aspect, the disclosure relates to a method of using the MRI/MRSI agents of the present disclosure to monitor the efficacy of a cancer treatment in a patient in need thereof.
METHOD FOR PRODUCING METAL CARBONATE AND CATALYST FOR PRODUCING THE SAME
A method for producing metal carbonate is disclosed. The method includes the following steps of providing a first mixture of metal and a catalyst containing iron, NO groups, and N-containing ligands first; then introducing carbon dioxide to the first mixture to form a second mixture and obtaining a product. The method described here can improve the yield and decrease the cost of metal carbonate production.
CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF
Described herein are corrole-based frameworks and methods for making the same. The corrole-based frameworks have unique structural and physical properties, which lends them to be versatile in a number of different applications and uses such as in gas storage/separation, proton conduction, biomedicine, sensing, and catalysis. In one aspect, the corrole-based frameworks are organic frameworks. In other aspects, the corrole-based frameworks are metal-organic frameworks.
First Row Transition Metal Amino Borohydrides
A transition metal amino borohydride material includes a first row transition metal in conjunction with an amine ligand and borohydride, in a condition of having been thermally treated to a temperature of at least 70° C. and up to but not including 800° C. An exemplary such material, Fe(DETA)(BH.sub.4).sub.2 having been heat treated at 300° C., had good hydrogen storage characteristics.